TSHB
Thyrotropin subunit beta
Also known as: TSHB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01222
- Gene
- TSHB
- Ensembl
- ENSG00000134200
- Chromosome
- 1
- Canonical length
- 138 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The four human glycoprotein hormones chorionic gonadotropin (CG), luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH) are dimers consisting of alpha and beta subunits that are associated noncovalently. The alpha subunits of these hormones are identical, however, their beta chains are unique and confer biological specificity. Thyroid stimulating hormone functions in the control of thyroid structure and metabolism. The protein encoded by this gene is the beta subunit of thyroid stimulating hormone. Mutations in this gene are associated with congenital central and secondary hypothyroidism and Hashimoto's thyroiditis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
138 residues, UniProt reviewed canonical sequence.
>P01222|TSHB
1 MTALFLMSML FGLTCGQAMS FCIPTEYTMH IERRECAYCL TINTTICAGY CMTRDINGKL
61 FLPKYALSQD VCTYRDFIYR TVEIPGCPLH VAPYFSYPVA LSCKCGKCNT DYSDCIHEAI
121 KTNYCTKPQK SYLVGFSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSHB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 1,603 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 1,603 nTPM
- adrenal gland: 0.6 nTPM
- heart muscle: 0.5 nTPM
- testis: 0.5 nTPM
- bone marrow: 0.4 nTPM
- cerebellum: 0.4 nTPM
Single-cell type
- late spermatids: 1.9 nCPM
- early spermatids: 1.3 nCPM
- hematopoietic stem cells: 1 nCPM
- pituitary stem cells: 0.7 nCPM
- late primary spermatocytes: 0.3 nCPM
- salivary myoepithelial cells: 0.3 nCPM
Immune cell
- NK-cell: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 1.3 nTPM
- thalamus: 1 nTPM
- amygdala: 0.8 nTPM
- medulla oblongata: 0.8 nTPM
- midbrain: 0.8 nTPM
- hypothalamus: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TSHB.
Disease | AllUniProt
Conditions TSHB is implicated in, by any mechanism.
- Hypothyroidism, congenital, non-goitrous, 4 (CHNG4) MIM:275100
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 83 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Isolated thyroid-stimulating hormone deficiency
- TSHB-related disorder
- Pituitary hypothyroidism
ReferencesPubMed · IEDB
Publications for TSHB from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Anti-Thyrotropin Autoantibodies in Patients with Macro-Thyrotropin and Long-Term Changes in Macro-Thyrotropin and Serum Thyrotropin Levels.
2017 · Thyroid · RCR 1.8 · 32 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.81
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSHB as an antibody target. Whether an autoantibody or antibody against TSHB could matter depends on whether native TSHB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSHB is annotated as secreted, so native TSHB circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TSHB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...